X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tetrazoles - pharmacology (5432) 5432
science & technology (5349) 5349
life sciences & biomedicine (5246) 5246
animals (4858) 4858
male (4388) 4388
humans (3259) 3259
rats (2992) 2992
pharmacology & pharmacy (2401) 2401
imidazoles - pharmacology (1805) 1805
female (1804) 1804
tetrazoles - therapeutic use (1788) 1788
angiotensin receptor antagonists (1746) 1746
biphenyl compounds - pharmacology (1680) 1680
blood pressure - drug effects (1584) 1584
cardiovascular system & cardiology (1553) 1553
losartan (1250) 1250
antihypertensive agents - pharmacology (1233) 1233
benzimidazoles - pharmacology (1216) 1216
hypertension - drug therapy (1122) 1122
rats, sprague-dawley (1100) 1100
valsartan (1066) 1066
middle aged (1056) 1056
angiotensin ii type 1 receptor blockers - pharmacology (1053) 1053
peripheral vascular disease (1038) 1038
valine - analogs & derivatives (1018) 1018
tetrazoles - administration & dosage (950) 950
dose-response relationship, drug (932) 932
hypertension (874) 874
adult (836) 836
angiotensin ii (836) 836
angiotensin ii - pharmacology (829) 829
mice (789) 789
aged (782) 782
antihypertensive agents - therapeutic use (771) 771
angiotensin (746) 746
cardiac & cardiovascular systems (702) 702
rats, wistar (696) 696
pyridines - pharmacology (687) 687
valine - pharmacology (668) 668
angiotensin ii - antagonists & inhibitors (623) 623
hypertension - physiopathology (610) 610
disease models, animal (596) 596
tetrazoles - chemistry (580) 580
angiotensin-converting enzyme inhibitors - pharmacology (538) 538
tetrazoles - pharmacokinetics (535) 535
angiotensin ii type 1 receptor blockers - therapeutic use (532) 532
time factors (530) 530
cells, cultured (525) 525
tetrazoles - adverse effects (512) 512
in vitro techniques (505) 505
angiotensin ii - metabolism (504) 504
treatment outcome (488) 488
receptor, angiotensin, type 1 (480) 480
blood pressure (470) 470
biphenyl compounds - therapeutic use (463) 463
drug therapy, combination (463) 463
rats, inbred shr (450) 450
renin-angiotensin system - drug effects (441) 441
physiology (440) 440
double-blind method (426) 426
benzimidazoles - therapeutic use (421) 421
tetrazoles (414) 414
abridged index medicus (410) 410
cilostazol (403) 403
imidazoles - therapeutic use (396) 396
chemistry (390) 390
valine - therapeutic use (390) 390
heart rate - drug effects (382) 382
antihypertensive agents - administration & dosage (366) 366
structure-activity relationship (364) 364
neurosciences & neurology (361) 361
receptors, angiotensin - metabolism (361) 361
analysis (353) 353
physical sciences (348) 348
administration, oral (346) 346
chemistry, medicinal (341) 341
hemodynamics - drug effects (338) 338
irbesartan (338) 338
kidney - drug effects (335) 335
biochemistry & molecular biology (330) 330
neurosciences (327) 327
rabbits (327) 327
research (326) 326
receptor, angiotensin, type 2 (323) 323
candesartan (310) 310
biphenyl compounds - administration & dosage (293) 293
tetrazoles - chemical synthesis (292) 292
tetrazoles - metabolism (287) 287
angiotensin ii - physiology (285) 285
drug therapy (284) 284
dogs (280) 280
renin-angiotensin system (279) 279
receptors, angiotensin - physiology (275) 275
renin-angiotensin system - physiology (275) 275
heart failure (273) 273
rats, inbred wky (268) 268
heart failure - drug therapy (264) 264
antihypertensive agents - adverse effects (263) 263
blood pressure - physiology (261) 261
rna, messenger - metabolism (259) 259
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7741) 7741
Japanese (244) 244
Chinese (77) 77
German (37) 37
French (22) 22
Russian (22) 22
Portuguese (13) 13
Spanish (13) 13
Italian (6) 6
Hungarian (4) 4
Czech (3) 3
Ukrainian (3) 3
Polish (2) 2
Romanian (2) 2
Danish (1) 1
Dutch (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug metabolism and disposition, ISSN 1521-009X, 09/2012, Volume 40, Issue 9, pp. 1744 - 1756
Interindividual variability in activity of uptake transporters is evident in vivo, yet limited data exist in vitro, confounding in vitro-in vivo extrapolation.... 
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Species Specificity | Valsartan | Hypoglycemic Agents - metabolism | Benzoates - metabolism | Humans | Antihypertensive Agents - metabolism | Hepatocytes - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 1 Receptor Blockers - metabolism | Organic Anion Transporters - metabolism | Pyrimidines - metabolism | Quinolines - pharmacology | Tetrazoles - metabolism | Carbamates - metabolism | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Biological Transport | Piperidines - pharmacology | Hepatocytes - drug effects | Carbamates - pharmacology | Pravastatin - pharmacology | Fluorobenzenes - metabolism | Piperidines - metabolism | Pravastatin - metabolism | Valine - analogs & derivatives | Rats | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Hypoglycemic Agents - pharmacology | Quinolines - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Valine - metabolism | Models, Biological | Benzimidazoles - metabolism | Sulfonamides - metabolism | Benzoates - pharmacology | Benzimidazoles - pharmacology | Kinetics | Valine - pharmacology | Organic Anion Transporters - drug effects | Index Medicus
Journal Article
Journal Article
Respiratory research, ISSN 1465-9921, 12/2011, Volume 12, Issue 1, pp. 1 - 8
The development of bronchial hyperreactivity (BHR) subsequent to precapillary pulmonary hypertension (PHT) was prevented by acting on the major signalling... 
Medicine & Public Health | Pneumology/Respiratory System | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Airway Resistance - drug effects | Iloprost - pharmacology | Bronchial Provocation Tests | Antihypertensive Agents - administration & dosage | Hypertension, Pulmonary - physiopathology | Male | Endothelins - metabolism | Sulfones - pharmacology | Lung Volume Measurements | Sildenafil Citrate | Time Factors | Vasoactive Intestinal Peptide - pharmacology | Bronchoconstriction - drug effects | Bronchial Hyperreactivity - physiopathology | Bronchial Hyperreactivity - metabolism | Blood Pressure - drug effects | Hypertension, Pulmonary - drug therapy | Lung - metabolism | Phosphodiesterase 5 Inhibitors - pharmacology | Endothelin Receptor Antagonists | Disease Models, Animal | Bronchial Hyperreactivity - etiology | Prostaglandins I - metabolism | Bronchial Hyperreactivity - therapy | Infusion Pumps, Implantable | Vasodilator Agents - pharmacology | Administration, Oral | Purines - pharmacology | Receptors, Endothelin - metabolism | Infusions, Parenteral | Rats | Hypertension, Pulmonary - metabolism | Lung - physiopathology | Piperazines - pharmacology | Rats, Sprague-Dawley | Animals | Analysis of Variance | Signal Transduction - drug effects | Lung - drug effects | Pyridines - pharmacology | Lung - blood supply | Nitric Oxide - metabolism | Vasodilator Agents - administration & dosage | Hypertension, Pulmonary - complications | Bronchi | Physiological aspects | Development and progression | Respiratory agents | Research | Drug therapy | Health aspects | Pulmonary hypertension | Prevention | Nitric oxide | Index Medicus
Journal Article
Psychopharmacology (Berlin, Germany), ISSN 1432-2072, 11/2012, Volume 226, Issue 2, pp. 357 - 369
Journal Article
Journal Article
Investigational new drugs, ISSN 0167-6997, 8/2013, Volume 31, Issue 4, pp. 833 - 844
The HGF/MET signaling pathway regulates a wide variety of normal cellular functions that can be subverted to support neoplasia, including cell proliferation,... 
Medicine & Public Health | MET inhibitor | Oncology | MST1R | Pharmacology/Toxicology | LY2801653 | ROS1 | MKNK | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Niacinamide - analogs & derivatives | Proto-Oncogene Proteins c-met - metabolism | Tetrazoles - pharmacology | Blood Vessels - pathology | Humans | Biological Availability | Antineoplastic Agents - administration & dosage | Indazoles - administration & dosage | Protein Kinase Inhibitors - chemistry | Tetrazoles - chemistry | Niacinamide - chemistry | Tetrazoles - administration & dosage | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Indazoles - chemistry | Administration, Oral | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Antineoplastic Agents - chemistry | Mutation - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Niacinamide - administration & dosage | Indazoles - pharmacology | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Blood Vessels - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Niacinamide - pharmacology | Complications and side effects | Enzyme inhibitors | Physiological aspects | Genetic aspects | Cellular signal transduction | Dosage and administration | Research | Drug therapy | Cancer | Studies | Pharmaceutical sciences | Tumors | Index Medicus | Preclinical Studies
Journal Article
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 04/1996, Volume 97, Issue 8, pp. 1916 - 1923
Journal Article